HCA Healthcare Inc., through its wholly owned subsidiary HCA Inc., has established a new commercial paper program as of June 10, 2025. This program allows HCA Inc. to issue unsecured commercial paper notes with a maximum aggregate principal amount of $4.0 billion outstanding at any time. These notes are unconditionally guaranteed by HCA Healthcare Inc. The program allows for borrowing, repayment, and reborrowing of funds, with maturities not exceeding 397 days from the date of issue. The proceeds from these notes will be utilized for general corporate purposes. The notes will be sold on a private placement basis in the U.S. commercial paper market and are not registered under the Securities Act of 1933.
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。